Krammer PH - Search Results

1

Up-regulation of Fas (CD95) expression in tumour cells in vivo.

Peshes-Yaloz N, Rosen D, Sondel PM, Krammer PH, Berke G. Peshes-Yaloz N, et al. Among authors: krammer ph. Immunology. 2007 Apr;120(4):502-11. doi: 10.1111/j.1365-2567.2006.02521.x. Immunology. 2007. PMID: 17343612 Free PMC article.

2

The regulation of CD95 ligand expression and function in CTL.

Li JH, Rosen D, Ronen D, Behrens CK, Krammer PH, Clark WR, Berke G. Li JH, et al. Among authors: krammer ph. J Immunol. 1998 Oct 15;161(8):3943-9. J Immunol. 1998. PMID: 9780162

3

In vitro generated human memory-like T cells are CD95 type II cells and resistant towards CD95-mediated apoptosis.

Fas SC, Baumann S, Krueger A, Frey CR, Schulze-Bergkamen H, Brenner D, Stumpf C, Kappes K, Krammer PH. Fas SC, et al. Among authors: krammer ph. Eur J Immunol. 2006 Nov;36(11):2894-903. doi: 10.1002/eji.200635925. Eur J Immunol. 2006. PMID: 17048269 Free article.

4

APO-1 (CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines.

Peter ME, Dhein J, Ehret A, Hellbardt S, Walczak H, Moldenhauer G, Krammer PH. Peter ME, et al. Among authors: krammer ph. Int Immunol. 1995 Nov;7(11):1873-7. doi: 10.1093/intimm/7.11.1873. Int Immunol. 1995. PMID: 8580085

5

The influence of CD95L expression on tumor rejection in mice.

Igney FH, Behrens CK, Krammer PH. Igney FH, et al. Among authors: krammer ph. Eur J Immunol. 2003 Oct;33(10):2811-21. doi: 10.1002/eji.200324176. Eur J Immunol. 2003. PMID: 14515265 Free article.

6

Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system.

Li-Weber M, Krammer PH. Li-Weber M, et al. Among authors: krammer ph. Semin Immunol. 2003 Jun;15(3):145-57. doi: 10.1016/s1044-5323(03)00030-7. Semin Immunol. 2003. PMID: 14563113 Review.

7

Segregation of APO-1/Fas antigen- and tumor necrosis factor receptor-mediated apoptosis.

Grell M, Krammer PH, Scheurich P. Grell M, et al. Among authors: krammer ph. Eur J Immunol. 1994 Oct;24(10):2563-6. doi: 10.1002/eji.1830241045. Eur J Immunol. 1994. PMID: 7523147

8

Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.

Müller KP, Mariani SM, Matiba B, Kyewski B, Krammer PH. Müller KP, et al. Among authors: krammer ph. Eur J Immunol. 1995 Oct;25(10):2996-9. doi: 10.1002/eji.1830251043. Eur J Immunol. 1995. PMID: 7589104

9

T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB.

Li-Weber M, Laur O, Dern K, Krammer PH. Li-Weber M, et al. Among authors: krammer ph. Eur J Immunol. 2000 Feb;30(2):661-70. doi: 10.1002/1521-4141(200002)30:2<661::AID-IMMU661>3.0.CO;2-L. Eur J Immunol. 2000. PMID: 10671224 Free article.

10

Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells.

Kirchhoff S, Müller WW, Li-Weber M, Krammer PH. Kirchhoff S, et al. Among authors: krammer ph. Eur J Immunol. 2000 Oct;30(10):2765-74. doi: 10.1002/1521-4141(200010)30:10<2765::AID-IMMU2765>3.0.CO;2-W. Eur J Immunol. 2000. PMID: 11069056 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

472 results

Search Page

Filters